top of page

INSIGHTS & ARTICLES

Medical device quality inspection and FDA regulatory compliance documentation

Medical device quality inspection and FDA regulatory compliance documentation

What FDA’s 2025 Enforcement Data Shows, and How Medical Device and IVD Manufacturers Should Prepare

ISO 14971 Risk Management File: FDA Submission Guide

ISO 14971 Risk Management File: FDA Submission Guide

Risk Management Files and Regulatory Scrutiny: A Guide for Medical Device Companies

Healthy aging and emerging healthcare technologies including precision medicine, gene therapy, medical wearables, and point-of-care diagnostics

Healthy aging and emerging healthcare technologies including precision medicine, gene therapy, medical wearables, and point-of-care diagnostics

The Pursuit of Healthy Aging: Innovations and Strategies

A 3D balance scale illustrating the evaluation of Companion Diagnostic (CDx) biomarker evidence against FDA regulatory requirements on a teal grid background. The left pan holds a glowing DNA double helix representing Biomarker / CDx data, while the right pan holds a building block with an FDA seal representing FDA Regulatory Requirements.

A 3D balance scale illustrating the evaluation of Companion Diagnostic (CDx) biomarker evidence against FDA regulatory requirements on a teal grid background. The left pan holds a glowing DNA double helix representing Biomarker / CDx data, while the right pan holds a building block with an FDA seal representing FDA Regulatory Requirements.

How Much Clinical Evidence Does FDA Require to Support a Biomarker Claim?

FDA Submission Guide for Foreign IVD Manufacturers

FDA Submission Guide for Foreign IVD Manufacturers

What Foreign IVD Manufacturers Need to Know Before Submitting to the FDA

Design History File Gaps That Cause FDA 483 Observations

Design History File Gaps That Cause FDA 483 Observations

Design History File Gaps That Cause FDA 483 Observations

2 3 4 5

bottom of page